Deciphera Pharmaceuticals

At Catalent, we believe that putting patients first isn't just a value - it's the foundation of everything we do. Our team of thousands of scientists and technicians across more than 40 global sites works collaboratively to transform bold ideas into life-changing therapies. We champion the missions that matter by partnering with pharma, biotech, and consumer health companies to accelerate the development, manufacturing, and delivery of products that improve lives worldwide. What sets Catalent apart is our unwavering commitment to unparalleled service and quality. From our origins in 1933 with R.P. Scherer's revolutionary softgel encapsulation process to becoming a leading global CDMO, we've continuously evolved our capabilities. Our integrated solutions span oral dose, biologics, specialty and clinical supply services, supported by advanced technologies and proven expertise. We deliver 60+ billion treatment doses annually, helping over 200 million patients each year. Our culture of innovation, integrity, and customer dedication means we don't just manufacture products - we help our partners bring their missions to life, reliably and at scale.

We're building a different kind of security platform because we saw how security teams were drowning in noise, struggling with fragmented tools, and spending too much time on manual tasks. Our Unified Defense SIEM brings everything together - SIEM, UEBA, SOAR, and threat intelligence - in one cloud-native platform that actually helps people work smarter. We don't just sell software and walk away. We've built our platform on Snowflake and AWS from the ground up because we wanted something that scales without breaking the budget and that gives teams real control over their data pipelines. Our Agentic AI handles the repetitive triage and investigation work so analysts can focus on what matters most. We've helped organizations cut storage and compute costs by up to 50 percent while improving analyst efficiency by the same margin - not by adding more tools, but by making the ones they have work together.

We're a global data and analytics software company pioneering Decision Intelligence, founded in London in 2016. Our Decision Intelligence Platform connects siloed systems and visualizes complex relationships to help organizations understand their data in the right context. We work with banks, insurers, telecoms companies, healthcare providers, and government agencies to help them make trusted operational decisions at strategic, operational, and tactical levels. Our platform uses advanced Entity Resolution, Graph Generation, and Contextual Analytics to create a single, trusted view of data that becomes a reusable resource across the organization. We help our customers detect and prevent financial crime and fraud, improve KYC processes, enhance customer intelligence, streamline risk assessment, and identify new revenue opportunities. When organizations need to act with confidence on the decisions that matter most, they turn to us.

PCI Pharma Services operates 38 pharmaceutical manufacturing and development facilities across seven countries, producing therapies that move through clinical trials to commercial distribution. With 8,500+ personnel handling everything from formulation development to packaging, the attack surface spans regulated manufacturing environments, clinical trial data systems, supply chain integration points, and quality management infrastructure that must satisfy FDA, EMA, and other regulatory frameworks. The threat model here is straightforward: any compromise of manufacturing systems could contaminate product batches, while breaches of clinical trial data or supply chain systems create both patient safety risks and massive regulatory exposure. The company supports 90+ product launches annually, meaning security teams must maintain operational technology (OT) security across pharmaceutical manufacturing lines, protect electronic batch records and quality management systems, and secure integrations with customers' value chains. Regulatory compliance isn't optional - GMP environments require validated systems, audit trails, and controls that meet 21 CFR Part 11 standards for electronic records. The technical domains span pharmaceutical development systems, manufacturing execution systems (MES), laboratory information management systems (LIMS), and clinical trial management platforms, all operating under continuous regulatory scrutiny. With facilities in the US, Canada, UK, Ireland, Germany, Spain, and Australia, the infrastructure operates across multiple regulatory jurisdictions with different data sovereignty requirements. The company has over 50 years in healthcare services, suggesting legacy systems that likely require modernization alongside newer cloud-based clinical and supply chain platforms. Security architecture must account for both operational continuity in manufacturing environments where downtime means product loss, and the protection of highly sensitive clinical trial data and proprietary drug formulations.

We're a team building identity security that actually works for the modern enterprise. Our platform helps you discover every identity - human, machine, and AI - manage their access, and catch threats in real time. We believe security shouldn't slow you down, which is why we built a cloud-native platform that deploys in weeks, not months, with 99.995% uptime. Delinea made Privileged Access Management seamless, but we knew that wasn't enough. Today's enterprises need identity controls that are intelligent, adaptive, and measurable. With Iris AI powering our platform, we're helping over a million identities stay secure daily across 500+ integrations. Our mission is straightforward: secure every identity so organizations can innovate confidently without the chaos of credential sprawl or standing privileges.

Sanimax is a pioneer in the circular economy, transforming organic waste into valuable industrial ingredients for over 85 years. Since 1939, this family-owned company has repurposed more than 2 million tons of agri-food by-products annually across the Americas, operating 17 facilities with a network of over 40,000 client sites. Their operations divert massive quantities of organic materials from landfills, generating five times fewer greenhouse gas emissions compared to traditional disposal methods. With 2,000+ employees across Canada, the United States, and Brazil, Sanimax has established itself as a leader in the rendering industry. Their three-step process - Reclaim, Renew, and Return - transforms used cooking oils, animal by-products, and organic materials into high-quality ingredients for animal nutrition, pet food, biofuels, and everyday products like paints and lubricants. This sustainable approach not only supports the food chain but also creates value from materials that would otherwise be waste.